Freestone Capital Holdings’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-500
| Closed | -$3.54K | – | 402 |
|
|
2023
Q1 | $3.54K | Hold |
500
| – | – | ﹤0.01% | 371 |
|
|
2022
Q4 | $3.21K | Hold |
500
| – | – | ﹤0.01% | 376 |
|
|
2022
Q3 | $7K | Hold |
500
| – | – | ﹤0.01% | 375 |
|
|
2022
Q2 | $9K | Hold |
500
| – | – | ﹤0.01% | 418 |
|
|
2022
Q1 | $15K | Hold |
500
| – | – | ﹤0.01% | 577 |
|
|
2021
Q4 | $22K | Buy |
+500
| New | +$22K | ﹤0.01% | 504 |
|